Cargando…
Early discontinuation of intravenous antimicrobial therapy in pediatric oncology patients with febrile neutropenia
BACKGROUND: There are no standard criteria for when to discontinue intravenous antimicrobial therapy (IVAMT) in children with febrile neutropenia (FN), but it is now common to discontinue IVAMT and discharge patients with an absolute neutrophil count (ANC) ≤ 500 /mm(3). The purpose of this study was...
Autores principales: | Hodgson-Viden, Heather, Grundy, Paul E, Robinson, Joan L |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2005
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1156908/ https://www.ncbi.nlm.nih.gov/pubmed/15904510 http://dx.doi.org/10.1186/1471-2431-5-10 |
Ejemplares similares
-
Febrile neutropenia in paediatric oncology
por: Davis, Kimberly, et al.
Publicado: (2020) -
Update on Febrile Neutropenia in Pediatric Oncological Patients Undergoing Chemotherapy
por: Cennamo, Federica, et al.
Publicado: (2021) -
The Pattern of Microorganisms and Drug Susceptibility in Pediatric Oncologic Patients with Febrile Neutropenia
por: Jungrungrueng, Thanyathorn, et al.
Publicado: (2021) -
Predictive Factors of Severe Adverse Events in Pediatric Oncologic Patients with Febrile Neutropenia
por: Thangthong, Jutarat, et al.
Publicado: (2020) -
Diagnosis and Management of Febrile Neutropenia in Pediatric Oncology Patients—A Systematic Review
por: Boeriu, Estera, et al.
Publicado: (2022)